相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Calcium Upregulation by Percutaneous Administration of Gene Therapy in Cardiac Disease (CUPID) A Phase 2 Trial of Intracoronary Gene Therapy of Sarcoplasmic Reticulum Ca2+-ATPase in Patients With Advanced Heart Failure
Mariell Jessup et al.
CIRCULATION (2011)
Mitigation of muscular dystrophy in mice by SERCA overexpression in skeletal muscle
Sanjeewa A. Goonasekera et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Calcium and the damage pathways in muscular dystrophy
David G. Allen et al.
CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY (2010)
Gene Delivery of Sarcoplasmic Reticulum Calcium ATPase Inhibits Ventricular Remodeling in Ischemic Mitral Regurgitation
Ronen Beeri et al.
CIRCULATION-HEART FAILURE (2010)
Sarcoplasmic reticulum Ca2+ ATPase as a therapeutic target for heart failure
Larissa Lipskaia et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2010)
SERCA2a Gene Transfer Enhances eNOS Expression and Activity in Endothelial Cells
Lahouaria Hadri et al.
MOLECULAR THERAPY (2010)
GENDER INFLUENCES CARDIAC FUNCTION IN THE mdx MODEL OF DUCHENNE CARDIOMYOPATHY
Brian Bostick et al.
MUSCLE & NERVE (2010)
Brief Report: Dystrophin Immunity in Duchenne's Muscular Dystrophy.
Jerry R. Mendell et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Leaky RyR2 trigger ventricular arrhythmias in Duchenne muscular dystrophy
Jeremy Fauconnier et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Genetic inhibition of PKA phosphorylation of RyR2 prevents dystrophic cardiomyopathy
Satyam Sarma et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Pathways of abnormal stress-induced Ca2+ influx into dystrophic mdx cardiomyocytes
M. Fanchaouy et al.
CELL CALCIUM (2009)
Systemic Trans-Splicing Adeno-Associated Viral Delivery Efficiently Transduces the Heart of Adult mdx Mouse, a Model for Duchenne Muscular Dystrophy
Arkasubhra Ghosh et al.
HUMAN GENE THERAPY (2009)
Calcium Upregulation by Percutaneous Administration of Gene Therapy in Cardiac Disease (CUPID Trial), a First-in-Human Phase 1/2 Clinical Trial
Brian E. Jaski et al.
JOURNAL OF CARDIAC FAILURE (2009)
Current understanding and management of dilated cardiomyopathy in Duchenne and Becker muscular dystrophy
Rita Wen Kaspar et al.
JOURNAL OF THE AMERICAN ACADEMY OF NURSE PRACTITIONERS (2009)
Cardiac Expression of a Mini-dystrophin That Normalizes Skeletal Muscle Force Only Partially Restores Heart Function in Aged Mdx Mice
Brian Bostick et al.
MOLECULAR THERAPY (2009)
Prevention of dystrophin-deficient cardiomyopathy in twenty-one-month-old carrier mice by mosaic dystrophin expression or complementary dystrophin/utrophin expression
Brian Bostick et al.
CIRCULATION RESEARCH (2008)
Adeno-associated virus serotype-9 microdystrophin gene therapy ameliorates electrocardiographic abnormalities in mdx mice
Brian Bostick et al.
HUMAN GENE THERAPY (2008)
Design of a phase 1/2 trial of intracoronary administration of AAV1/SERCA2a in patients with heart failure
Roger J. Hajjar et al.
JOURNAL OF CARDIAC FAILURE (2008)
Reversal of cardiac dysfunction after long-term expression of SERCA2a by gene transfer in a pre-clinical model of heart failure
Yoshiaki Kawase et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2008)
Effective rescue of dystrophin improves cardiac function in dystrophin-deficient mice by a modified morpholino oligomer
Bo Wu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
The cardiac sarcoplasmic/endoplasmic reticulum calcium ATPase: a potent target for cardiovascular diseases
Yoshiaki Kawase et al.
NATURE CLINICAL PRACTICE CARDIOVASCULAR MEDICINE (2008)
Systemic AAV-9 transduction in mice is influenced by animal age but not by the route of administration
B. Bostick et al.
GENE THERAPY (2007)
Restoration of mechanical and energetic function in failing aortic-banded rat hearts by gene transfer of calcium cycling proteins
Susumu Sakata et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2007)
C-terminal-truncated microdystrophin recruits dystrobrevin and syntrophin to the dystrophin-associated glycoprotein complex and reduces muscular dystrophy in symptomatic utrophin/dystrophin double-knockout mice
Yongping Yue et al.
MOLECULAR THERAPY (2006)
New insights in the regulation of calcium transfers by muscle dystrophin-based cytoskeleton: implications in DMD
Bruno Constantin et al.
JOURNAL OF MUSCLE RESEARCH AND CELL MOTILITY (2006)
Utrophin deficiency worsens cardiac contractile dysfunction present in dystrophin-deficient mdx mice
PML Janssen et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2005)
Efficient in vivo gene expression by trans-splicing adeno-associated viral vectors
Y Lai et al.
NATURE BIOTECHNOLOGY (2005)
Dystrophic heart failure blocked by membrane sealant poloxamer
S Yasuda et al.
NATURE (2005)
Effect of cyclopiazonic acid, an inhibitor of the sarcoplasmic reticulum Ca-ATPase, on skeletal muscles from normal and mdx mice
A Divet et al.
ACTA PHYSIOLOGICA SCANDINAVICA (2005)
Decreased mAKAP, ryanodine receptor, and SERCA2a gene expression in mdx hearts
MS Rohman et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2003)
Microdystrophin gene therapy of cardiomyopathy restores dystrophin-glycoprotein complex and improves sarcolemma integrity in the mdx mouse heart
YP Yue et al.
CIRCULATION (2003)
Sarcoplasmic reticulum Ca2+-ATPase modulates cardiac contraction and relaxation
KF Frank et al.
CARDIOVASCULAR RESEARCH (2003)